Title:
癌の治療のための免疫調節薬の組み合わせおよび方法
Document Type and Number:
Japanese Patent JP2022516093
Kind Code:
A
Abstract:
本開示の実施形態は、組み合わせ療法を用いて癌を治療するための免疫調節組成物、および方法に関する。【選択図】図１Ａ
Inventors:
Li, ricin
Lau, Walter
Lau, Walter
Application Number:
JP2021537786A
Publication Date:
February 24, 2022
Filing Date:
December 17, 2019
Export Citation:
Assignee:
Birdie By Offer Matthew Ticals Incorporated
International Classes:
A61K45/06; A61K31/337; A61K31/403; A61K31/4745; A61K31/506; A61K31/513; A61K31/704; A61K31/7068; A61K33/24; A61K39/395
Domestic Patent References:
| JP2017521421A | 2017-08-03 | |||
| JP2017521420A | 2017-08-03 |
Other References:
"Systemic administration of a TLR7 agonist attenuates regulatory T cells by dendritic cell modificati", ONCOTARGET, vol. 9, no. 17, JPN6023030495, 2 March 2018 (2018-03-02), pages 13301 - 13312, ISSN: 0005114133
Attorney, Agent or Firm:
Kimura Mitsuru
Yasushi Morikawa
Kei Sakurada
Hideki Mie
Yasushi Morikawa
Kei Sakurada
Hideki Mie
Previous Patent: Fragment size characterization of cell-free DNA mutations from clonal hematopoies
Next Patent: Combined inter and intra forecasts
Next Patent: Combined inter and intra forecasts